VYNKELLA 61 MG CAP MOLE CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1211004890012 -
GGREM
522723050092302 -
Código de barras
7891045164245
O que a fonte publica
- Detentor do registro
- PFIZER BRASIL LTDA
- Princípios ativos
- TAFAMIDIS
- Embalagem
- 61 MG CAP MOLE CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- N7X - TODOS OS OUTROS PRODUTOS PARA O SISTEMA NERVOSO CENTRAL
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "VYNKELLA 61 MG CAP MOLE CT BL AL AL X 30",
"holder": "PFIZER BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891045164245"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "522723050092302",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.072.393/0001-33",
"priceRegime": "Regulado",
"productName": "VYNKELLA",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "61 MG CAP MOLE CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "49273.00",
"icms-12": "55992.06",
"icms-17": "59365.05",
"icms-18": "60089.01",
"icms-19": "60830.87",
"icms-20": "61591.25",
"icms-21": "62370.90",
"icms-22": "63170.50",
"icms-23": "63990.89",
"icms-17.5": "59724.84",
"icms-19.5": "61208.69",
"icms-20.5": "61978.63",
"icms-22.5": "63578.09",
"icms-12-alc": "49992.93",
"icms-17-alc": "53004.49",
"icms-18-alc": "53650.91",
"icms-19-alc": "54313.23",
"icms-20-alc": "54992.17",
"icms-21-alc": "55688.30",
"icms-22-alc": "56402.21",
"icms-23-alc": "57134.70",
"withoutTaxes": "43993.74",
"icms-17.5-alc": "53325.75",
"icms-19.5-alc": "54650.61",
"icms-20.5-alc": "55338.01",
"icms-22.5-alc": "56766.09"
},
"pisCofinsList": "Negativa",
"substanceText": "TAFAMIDIS",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "66097.98",
"icms-12": "75111.35",
"icms-17": "79636.10",
"icms-18": "80607.27",
"icms-19": "81602.45",
"icms-20": "82622.47",
"icms-21": "83668.34",
"icms-22": "84740.98",
"icms-23": "85841.50",
"icms-17.5": "80118.75",
"icms-19.5": "82109.28",
"icms-20.5": "83142.13",
"icms-22.5": "85287.74",
"icms-12-alc": "69112.29",
"icms-17-alc": "73275.60",
"icms-18-alc": "74169.24",
"icms-19-alc": "75084.85",
"icms-20-alc": "76023.45",
"icms-21-alc": "76985.81",
"icms-22-alc": "77972.75",
"icms-23-alc": "78985.37",
"withoutTaxes": "60818.77",
"icms-17.5-alc": "73719.72",
"icms-19.5-alc": "75551.26",
"icms-20.5-alc": "76501.55",
"icms-22.5-alc": "78475.79"
},
"invalidBarcodes": [],
"activeSubstances": [
"TAFAMIDIS"
],
"therapeuticClass": "N7X - TODOS OS OUTROS PRODUTOS PARA O SISTEMA NERVOSO CENTRAL",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1211004890012",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N7X",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:522723050092302"